BS

Biren Surukumar Desai

Active Director Director DIN 11252148
DIN 11252148 First appointment Aug 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Biren Surukumar Desai

Data last updated:

Biren Surukumar Desai is a Director at Neuroregen Healthcare Private Limited (since 2025). The company operates in Healthcare.

DIN 11252148
Primary Designation Director
Industry Healthcare
First Appointment 21 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Aug 20252025Active

Directorship timeline

Open interactive timeline →
Neuroregen Healthcare Private Limited
Premium access

Shareholding and investment profile for Biren Surukumar Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biren Surukumar Desai

Biren Surukumar Desai currently holds 1 directorship: Neuroregen Healthcare Private Limited (Director, since 21 Aug 2025).

Biren Surukumar Desai was first appointed on 21 Aug 2025 as Director at Neuroregen Healthcare Private Limited.

The current boards of Biren Surukumar Desai's companies include Anjana Rani Nair (Neuroregen Healthcare Private Limited), Lakshmiah Ramakrishna Dhananjaya (Neuroregen Healthcare Private Limited), Malepati Karthik (Neuroregen Healthcare Private Limited), Raghu Pillai (Neuroregen Healthcare Private Limited), Thaya Veetal Rigesh (Neuroregen Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available